Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases

RNA

Volumn 4, Issue 2, 1998, Pages 215-225

  Blair, Wade S ^a,c   Parsley, Todd B ^b   Bogerd, Hal P ^a   Towner, Jonathan S ^b   Semler, Bert L ^b   Cullen, Bryan R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

5' noncoding region; HIV 1 Tat; In vivo RNA protein binding; Poliovirus; RNA structure

Indexed keywords

PROTEINASE; RNA; TRANSACTIVATOR PROTEIN; VIRUS ENZYME;

ARTICLE; ASSAY; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MAMMAL CELL; NONHUMAN; PICORNAVIRUS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN RNA BINDING; RHINOVIRUS; RNA SEQUENCE;

BASE SEQUENCE; BINDING SITES; CHLORAMPHENICOL O-ACETYLTRANSFERASE; ENDOPEPTIDASES; GENE PRODUCTS, TAT; GENES, REPORTER; HELA CELLS; HIV LONG TERMINAL REPEAT; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PICORNAVIRIDAE; POLIOVIRUS; RHINOVIRUS; RNA, VIRAL; SUBSTRATE SPECIFICITY; TRANS-ACTIVATION (GENETICS); TRANSFECTION;

EID: 0031917684     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Allaire M, Chernaia MM, Malcolm BA, James MNG. 1994. Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. Nature 369:72-76.
2. Andino R, Rieckhof GE, Achacoso PL, Baltimore D. 1993. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′-end of viral RNA. EMBO J 12:3587-3598.
3. Andino R, Rieckhof GE, Baltimore D. 1990a. A functional ribonucleo-protein complex forms around the 5′ end of poliovirus RNA. Cell 63:369-380.
4. Andino R, Rieckhof GE, Trono D, Baltimore D. 1990b. Substitutions in the protease (3Cpro) gene of poliovirus can suppress a mutation in the 5′ noncoding region. J Virol 64:607-612.
5. Bergmann EM, Mosimann SC, Chernaia MM, Malcolm BA, James MNG. 1997. The refined crystal structure of the 3C gene product from hepatitis A virus: Specific proteinase activity and RNA recognition. J Virol 71:2436-2448.
6. Blair WS, Nguyen JHC, Parsley TB, Semler BL 1996. Mutations in the poliovirus 3CD proteinase S1-specificity pocket affect substrate recognition and RNA binding. Virology 218:1-13.
7. Blair WS, Semler BL 1991. Role for the P4 amino acid residue insubstrate utilization by the poliovirus 3CD proteinase. J Virol 65:6111-6123.
8. Borman AM, Deliat FG, Kean KM. 1994. Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. EMBO J 13:3149-3157.
9. Braddock M, Chambers A, Wilson W, Esnouf MP, Adams SE, Kingsman AJ, Kingsman SM. 1989. HIV-1 TAT "activates" presynthesized RNA in the nucleus. Cell 58:269-279.
10. Cullen BR. 1987. Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol 152:684-704.
11. Cullen BR. 1993. Does HIV-1 Tat induce a change in viral initiation rights? Cell 73:417-420.
12. Dasgupta A, Baron MH, Baltimore D. 1979. Poliovirus replicase: A soluble enzyme able to initiate copying of poliovirus RNA. Proc Natl Acad Sci USA 76:2679-2683.
13. Dewalt PG, Semler BL. 1989. Molecular biology and genetics of poliovirus protein processing. In: Semler BL, Ehrenfeld E, eds. Molecular aspects of picornavirus infection and detection. Washington DC: American Society for Microbiology, pp 73-93.
14. Dougherty WG, Semler BL. 1993. Expression of virus-encoded proteinases: Functional and structural similarities with cellular enzymes. Microbiol Rev 57:781-822.
15. Ehrenfeld E, Semler BL 1995. Anatomy of the poliovirus internal ribosome entry site. Curr Topics Microbiol Immunol 203:65-83.
16. Fridell RA, Harding LS, Bogerd HP, Cullen BR. 1995. Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology 209:347-357.
17. Haller AA, Semler BL. 1992. Linker scanning mutagenesis of the internal ribosome entry site of poliovirus RNA. J Virol 66:5075-5086.
18. Hämmerle T, Molla A, Wimmer E. 1992. Mutational analysis of the proposed FG loop of poliovirus proteinase 3C identifies amino acids that are necessary for 3CD cleavage and might be determinants of a function distinct from proteolytic activity. J Virol 66:6028-6034.
19. Hanecak R, Semler BL, Anderson CW, Wimmer E. 1982. Proteolytic processing of poliovirus polypeptides: Antibodies to polypeptide P3-7c inhibit cleavage a glutamine-glycine pairs. Proc Natl Acad Sci USA 79:3973-3977.
20. Harris KS, Xiang W, Alexander L, Lane WS, Paul AV, Wimmer E. 1994. Interaction of poliovirus polypeptide 3CDpro with the 5′ and 3′ termini of the poliovirus genome: Identification of viral and cellular cofactors needed for efficient binding. J Biol Chem 269:27004-27014.
21. Heguy A, Stewart AA, Haley JD, Smith DE, Foulkes JG. 1995. Gene expression as a target for new drug discovery. Gene Expression 4:337-344.
22. Jang SK, Kräusslich HG, Nicklin MJH, Duke GM, Palmenberg AC, Wimmer E. 1988. A segment of the 5′ untranslated region of encephalomyelitis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62:2636-2643.
23. Jore J, De Deus B, Jackson RJ, Pouweis PH, Enger-Valk BE. 1988. Poliovirus protein 3CD is the active protease for processing of the precursor protein P1 in vitro. J Gen Virol 69:1627-1636.
24. Kitamura T, Onishi M, Kinoshita S, Shibuya A, Miyajima A. 1995. Efficient screening of retroviral cDNA expression libraries. Proc Natl Acad Sci USA 92:9146-9150.
25. pro) to secondary structure elements within the 5′ terminus of the HAV genome. RNA 3:291-302.
26. pro) binds specifically to the 5′-noncoding region of the viral RNA. J Biol Chem 260:25735-25739.
27. Lundquist RE, Maizel JV. 1978. In vivo regulation of the poliovirus RNA polymerase. Virology 89:484-493.
28. Madore SJ, Cullen BR. 1993. Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J Virol 67:3703-3711.
29. Matthews DA, Smith WW, Ferre RA, Condon B, Budahazi G, Sisson W, Villafranca JE, Janson CA, McElroy HE, Gribskov CL, Worland S. 1994. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 77:761-771.
30. Nicklin MJH, Toyoda H, Murray MG, Wimmer E. 1986. Proteolyticprocessing in the replication of polio and related viruses. Biotechnology 4:36-42.
31. Pallai PV, Burkhardt F, Skoog M, Schreiner K, Baxt P, Cohen KA, Hansen G, Palladino DEH, Harris KS, Nicklin MJ, Wimmer E. 1989. Cleavage of synthetic peptides by purified poliovirus 3C proteinase. J Biol Chem 264:9738-9741.
32. Parsley TB, Towner JS, Blyn LB, Ehrenfeld E, Semler BL 1997. Poly (rC) binding protein 2 forms a ternary complex with the 5′-terminal sequences of poliovirus RNA and the viral 3CD protein-ase. RAM 3:1124-1134.
33. Pelletier J, Sonenberg N. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320-325.
34. Pendergrast PS, Hernandez N. 1997. RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat. J Virol 71:910-917.
35. Rohll JB, Percy N, Ley R, Evans DJ, Almond JW, Barclay W. 1994. The 5′-untranslated regions of picornavirus RNAs contain independent functional domains essential for RNA replication and translation. J Virol 68:4384-4391.
36. Selby MJ, Peterlin BM. 1990. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein. Cell 62:769-776.
37. SenGupta DJ, Zhang B, Kraemer B, Pochart P, Fields S, Wickens M. 1996. A three-hybrid system to detect RNA-protein interactions in vivo. Proc Natl Acad Sci USA 93:8496-8501.
38. Shiroki K, Ishii T, Aoki T, Kobashi M, Ohka S, Nomoto A. 1995. A new cis-acting element for RNA replication within the 5′ noncoding region of poliovirus type 1 RNA. J Virol 69:6825-6832.
39. Southgate CD, Green MR. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: Implications for Tat function. Genes & Dev 5:2496-2507.
40. Tiley LS, Madore SJ, Malim MH, Cullen BR. 1992. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes & Dev 6:2077-2087.
41. Todd S, Towner JS, Semler BL 1997. Translation and replication properties of the human rhinovirus genome in vivo and in vitro. Virology 229:90-97.
42. Walker PA, Leong LEC, Porter AG. 1995. Sequence and structural determinants of the interaction between the 5′-noncoding region of picornavirus RNA and rhinovirus protease 3C. J Biol Chem 270:14510-14516.
43. pro of poliovirus is essential for RNA replication. J Virol 69:3658-3667.
44. Ypma-Wong MF, Dewalt PG, Johnson VH, Lamb JG, Semler BL 1988a. Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 precursor. Virology 166:265-270.
45. Ypma-Wong MF, Filman DJ, Hogle JM, Semler BL. 1988b. Structural domains of the poliovirus polyprotein are major determinants for proteolytic cleavage at gln-gly pairs. J Biol Chem 63:17846-17856.